Clinical TrialsSearch results
Number of results: 683
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination with Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
- Relapsed or Refractory Multiple Myeloma
- Nakama Takahiro
- 2022-10-07
Recruiting
- Phase I/II trial for safety and pharmacokinetics of ENDOPIN in healthy adults and patients with pain
- Phase 1 part: Healthy adult male Phase 2 part: Postoperative pain patients
- Nakajima Takako
- 2023-01-04
Recruiting
- Phase I Single-Administration Study of TRG035 in Healthy Adults
- congenital anodontia
- Nakajima Takako
- 2024-10-08
Other
- Effect research on the interaction between brain and biological signals due to pain and the mind-body correlation
- none
- Nakae Aya
- 2025-03-04
Completed
- A Study of Robotic Pyeloplasty
- Ureteropelvic junction Obstruction
- Naitoh Yasuyuki
- 2019-03-11
Other
- Exercise and Life Functioning in Patients with Congestive Heart Failure ; A Rehabilitation Cohort Study.
- Patients with congestive heart failure
- Nagoya University School of Health Sciences
- 2007-12-01
Other
- A multicenter, observational study for reactivation of hepatitis B virus by means of serial HBV-DNA monitoring during and just after systemic chemotherapy containing rituximab plus steroid for malignant lymphoma (C-SHOT 0802)
- Untreated CD20-positive, B-cell non-Hodgkin's lymphoma in the patients with seronegativity for HBsAg and seropositivity for HBc-Ab and/or HBs-Ab, which is planned to be treated with 6-8 courses of systemic chemotherapy containing rituximab plus steroid such as R-CHOP, R-CVP, R-THP-COP and R-C-MOPP
- Nagoya City University Hospital
- 2008-08-11
Completed
- Exploratory research on Anti-SARS-CoV-2 testing
- COVID-19 patients
- Nagao Miki
- 2021-03-17
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation
- Multiple Myeloma
- Myeloma Bone Disease Study Group
- 2008-10-17